Horizon Kinetics Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-878
Closed -$236K 352
2020
Q3
$236K Hold
878
0.01% 324
2020
Q2
$231K Buy
+878
New +$234K 0.01% 322
2020
Q1
Sell
-878
Closed -$265K 412
2019
Q4
$265K Hold
878
0.01% 427
2019
Q3
$211K Hold
878
0.01% 450
2019
Q2
$248K Sell
878
-23
-3% -$6.28K 0.01% 436
2019
Q1
$259K Buy
+901
New +$261K 0.01% 435

Other funds holding ELV

Horizon Kinetics Asset Management's ELV Position: Q4 2020 in Review

Horizon Kinetics Asset Management sold out of Elevance Health (ELV) in Q4 2020, closing a stake of 878 shares — an estimated $236K sold.

Horizon Kinetics Asset Management first reported a position in ELV in Q1 2019 and held it in 6 quarters. The position peaked at $265K in Q4 2019. 1,170 funds tracked by Wall St. Rank hold ELV as of Q4 2020.

  • Horizon Kinetics Asset Management reported no remaining Elevance Health position as of Q4 2020 after selling out during the quarter.
  • Horizon Kinetics Asset Management sold 878 Elevance Health shares in Q4 2020, an estimated $236K.
  • Horizon Kinetics Asset Management first reported a position in Elevance Health in Q1 2019 and held it in 6 quarters.
  • Horizon Kinetics Asset Management's Elevance Health position peaked at $265K in Q4 2019.
  • 1,170 funds tracked by Wall St. Rank held Elevance Health as of Q4 2020.

Based on Horizon Kinetics Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.